Rosiglitazone and Myocardial Infarction in Patients Previously Prescribed Metformin
Colin R. Dormuth, Malcolm Maclure, Greg Carney et al. · 2009
Read Rosiglitazone and Myocardial Infarction in Patients Previously Prescribed Metformin by Colin R. Dormuth, Malcolm Maclure, Greg Carney et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0006080.txt.
Description
A diabetes drug came under a cloud when pooled trials linked it to heart attacks. Colin Dormuth, Malcolm Maclure, Greg Carney and colleagues checked that signal in everyday care in 2009. Their PLOS ONE paper estimates the link between rosiglitazone and acute myocardial infarction in real-world patients who had previously been prescribed metformin.
Trial pools had suggested a rise in risk of roughly forty percent, a signal strong enough to demand a real-world test. Patients already on metformin form a group where the drug was often added next. The study shows how safety questions move from trials to practice, and it gives prescribers evidence drawn from people like their own patients.
Catalog record
| CREATOR | Colin R. Dormuth, Malcolm Maclure, Greg Carney et al. |
|---|---|
| YEAR | 2009 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 35 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0006080